Dr. Michael Patrick Troy, MD

Dr. Troy practices at Peter Morton UCLA Medical Building in Los Angeles, California.

Dr. Troy's NPI, 1487017810, was assigned on April 2, 2016. Dr. Troy graduated from University of North Carolina School of Medicine in 2016. Dr. Troy holds California license A156542.

Dr. Troy's primary practice is Peter Morton UCLA Medical Building, at 200 Medical Plz, Los Angeles, CA 90024 in Los Angeles County. The practice phone is (310) 794-9206.

Dr. Troy's primary practice is Peter Morton UCLA Medical Building in Los Angeles, California. Dr. Troy is also affiliated with Ronald Reagan UCLA Medical Center. The medical group on file is UCLA Medical Group. Dmand AI also links Dr. Troy to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Troy practices, 3 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Troy's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Troy is board certified in critical care medicine by the American Board of Internal Medicine. Dr. Troy is licensed in California.

CMS data shows 247 Medicare services from Dr. Troy across 6 procedure codes in 2024, for 116 Medicare patients. Medicare paid $29,223 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 116 Medicare patients who saw Dr. Troy in 2024. The largest group is 65 to 74, with 39 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 34% are also on Medicaid. Their average risk score is 3.09, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Troy's median patient age at 58, with 54% women.

In 2024, Dr. Troy wrote 145 Medicare Part D claims for 45 patients. 44% of them were for generic drugs. CMS names the drug for 14 of them, across 1 drug with 11 or more claims each, at $792 in total drug cost. In 2023, CMS named 28 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Troy for performance year 2024, reported as part of a group. Dr. Troy accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Troy as offering telehealth.

CMS Open Payments shows 119 general payments to Dr. Troy from 12 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 100% of the total. Actelion Pharmaceuticals US, Inc. paid the most, $1,989.

Dr. Troy graduated from University of North Carolina School of Medicine in 2016.

Dr. Troy is in network with 6 carriers, including Elevance, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.